Risken för kranskärlssjukdom minskade med 42% (absolut riskreduktion med 3, 5%). ###>The risk of CHD death was reduced by 42% (absolute risk reduction of 3.5%) .< Zocord > also decreased the risk of having major coronary events (CHD death plus hospital-verified and silent nonfatal MI) by 34%.